Vitreous and Serum Levels of Platelet-Derived Growth Factor and Their Correlation in Patients with Proliferative Diabetic Retinopathy
Authors:
- Anna PraidouAPAnna Praidou
- Ioannis KlangasIKIoannis Klangas
- Eleni PapakonstantinouEPEleni Papakonstantinou
- Sofia AndroudiSASofia Androudi
- Nikolaos GeorgiadisNGNikolaos Georgiadis
- George KarakiulakisGKGeorge Karakiulakis
- Stavros DimitrakosSDStavros Dimitrakos
- 1 January 2009
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 34 (2) , 152-161
Abstract
We investigated possible correlations between vitreous and/or serum levels of platelet derived growth factor isoforms (PDGF-AA, -AB, -BB) with parameters associated with proliferative diabetic retinopathy (PDR), and compared the results to vascular endothelial growth factor (VEGF), which is an established growth factor affecting PDR. Thirty-one patients with PDR and 15 non-diabetic patients were included in the study. Vitreous and serum samples were obtained during vitrectomy. PDGF-AA, -AB, and -BB, as well as VEGF, were measured by enzyme-linked immunosorbent assay. PDGF-AA, -AB, -BB, and VEGF were all expressed in serum and vitreous of controls and patients with PDR. The levels of all PDGF isoforms and VEGF in vitreous were significantly increased in the PDR group, as compared to controls. No such differences were evident in serum. PDGF-AA and PDGF-BB correlated significantly to the severity but not the activity of PDR. PDGF-AB and -BB were significantly lower in vitreous of patients with pre-performed complete panretinal photocoagulation (PRP) as compared to incomplete or without PRP. PDGF did not correlate significantly to fibrovascular tissue, on the disc or elsewhere, to long-standing vitreous hemorrhage, to tractional retinal detachment, or to posterior vitreous detachment. PDGF or VEGF in vitreous or serum of PDR patients did not correlate with the serum levels of HbA1C. There was no correlation between the vitreous and serum levels of VEGF or PDGF in patients with PDR. It appears that, in addition to VEGF, PDGF-AA, -AB, and -BB in the vitreous are also correlated with PDR.Keywords
This publication has 31 references indexed in Scilit:
- Anti-vascular endothelial growth factor therapy for ocular neovascular diseaseCurrent Opinion in Ophthalmology, 2007
- INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)Retina, 2006
- Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profilesExperimental Eye Research, 2006
- Vitreous Levels of Pigment Epithelium–Derived Factor and Vascular Endothelial Growth Factor Are Related to Diabetic Macular EdemaOphthalmology, 2006
- Correlation Between Angiotensin-converting Enzyme, Vascular Endothelial Growth Factor, and Matrix Metalloproteinase-9 in the Vitreous of Eyes With Diabetic RetinopathyAmerican Journal of Ophthalmology, 2006
- Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomyOphthalmology, 2004
- Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin IIBritish Journal of Ophthalmology, 2004
- Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathyAmerican Journal of Ophthalmology, 2002
- Quantification of Thrombocyte Growth Factors in Platelet Concentrates Produced by Discontinuous Cell SeparationGrowth Factors, 2002
- Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathyExperimental and Clinical Endocrinology & Diabetes, 2000